Want to see TSE:BLO full AI Analyst Report?
BLO Stock Chart & Stats
C$0.60
-C$0.02(-4.76%)
At close: 4:00 PM EST
C$0.60
-C$0.02(-4.76%)
Day’s Range― - ―
52-Week RangeC$0.46 - C$0.95
Previous CloseN/A
Volume15.24K
Average Volume (3M)36.45K
Market Cap
C$64.97M
Enterprise ValueC$69.22M
Total Cash (Recent Filing)C$1.26M
Total Debt (Recent Filing)C$51.31K
Price to Earnings (P/E)―
Beta0.06
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding122,584,110
10 Day Avg. Volume30,616
30 Day Avg. Volume36,452
Financial Highlights & Ratios
PEG Ratio-0.30
Price to Book (P/B)27.07
Price to Sales (P/S)0.00
P/FCF Ratio-37.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Balance Sheet SolvencyLow leverage meaningfully reduces near-term solvency risk and preserves financial flexibility over the next several months. For a development-stage device company, modest debt improves ability to pursue R&D, regulatory pathways, and partnership negotiations without immediate debt-service pressure, supporting durability while cash burn is addressed.
Focused Product Niche And Clear Use CasesA concentrated product focus on breath-testing for THC and alcohol creates a clear addressable market (roadside and workplace impairment screening). Structural needs for impairment testing and workplace safety create enduring demand drivers, giving the company a defensible commercial pathway if its technology attains regulatory validation and adoption.
Early Revenue Growth SignalReported high revenue growth off a small base suggests early commercial traction or pilot activity, indicating product-market fit potential. While revenue remains modest, a consistent growth trend is a durable positive — it evidences initial customer uptake and provides a foundation to scale commercial operations if financing and regulatory clearances progress.
Bears Say
Persistent Negative Cash FlowConsistent negative operating and free cash flow creates an enduring reliance on external financing, increasing dilution and execution risk. Over a 2–6 month horizon this constrains R&D, regulatory submissions, and commercialization efforts; absent fresh capital the company may be forced to slow programs or seek value-eroding funding.
Deeply Negative MarginsMaterially negative gross and net margins indicate the company has not achieved viable unit economics. This is a structural concern because even with revenue expansion, sustained losses imply pricing, production, or cost-structure issues that must be resolved for durable profitability; otherwise losses will persist as scale grows.
Eroding Equity And Asset BaseA materially shrinking equity and asset base reflects cumulative losses and weak capital retention. This trend reduces balance-sheet resilience, limits borrowing capacity, and undermines investor confidence over the medium term. Continued erosion would impair the firm's ability to fund regulatory milestones and commercial rollout without dilutive financing.
Cannabix Technologies News
BLO FAQ
What was Cannabix Technologies Inc’s price range in the past 12 months?
Cannabix Technologies Inc lowest stock price was C$0.46 and its highest was C$0.95 in the past 12 months.
What is Cannabix Technologies Inc’s market cap?
Cannabix Technologies Inc’s market cap is C$64.97M.
When is Cannabix Technologies Inc’s upcoming earnings report date?
Cannabix Technologies Inc’s upcoming earnings report date is Aug 27, 2026 which is in 58 days.
How were Cannabix Technologies Inc’s earnings last quarter?
Cannabix Technologies Inc released its earnings results on Mar 25, 2026. The company reported -C$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.003.
Is Cannabix Technologies Inc overvalued?
According to Wall Street analysts Cannabix Technologies Inc’s price is currently Overvalued.
Does Cannabix Technologies Inc pay dividends?
Cannabix Technologies Inc does not currently pay dividends.
What is Cannabix Technologies Inc’s EPS estimate?
Cannabix Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannabix Technologies Inc have?
Cannabix Technologies Inc has 122,584,110 shares outstanding.
What happened to Cannabix Technologies Inc’s price movement after its last earnings report?
Cannabix Technologies Inc reported an EPS of -C$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.317%.
Which hedge fund is a major shareholder of Cannabix Technologies Inc?
Currently, no hedge funds are holding shares in TSE:BLO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cannabix Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
17.02%
12-Months-Change
Fundamentals
Return on Equity
-302.99%
Trailing 12-Months
Asset Growth
-38.24%
Trailing 12-Months
Company Description
Cannabix Technologies Inc
Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) for Tetrahydrocannabinol (THC) detection and quantification; Cannabix breath collection unit and breath cartridge for human breath sample collection, storage, and transportation. The company also provides BreathLogix alcohol breathalyzer, an autonomous alcohol screening system that enables screening of employees, contractors, and visitors in mining, construction, and oil and gas industries; and BreathLogix Connect (BLC), a cloud platform that is designed for streamlining data. It has a strategic partnership and development agreement with Omega Laboratories Inc. for the development and commercialization of the MBT technology. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.
Technical Analysis
Options Prices
Currently, No data available
---